Merz Showcases Data across Multiple Injectable and Device Products at American Academy of Dermatology Annual Meeting

Merz Americas today announced the presentation of data, including one oral presentation, from studies of its aesthetics products, including Xeomin (incobotulinumtoxinA), Ultherapy, Radiesse and the Cellfina System, at the American Academy of Dermatology (AAD) annual meeting, March 1-5, in Washington, DC.